Monopar Therapeutics, Inc. (MNPR)
59.27
-1.72
(-2.82%)
USD |
NASDAQ |
May 15, 16:00
59.42
+0.15
(+0.25%)
After-Hours: 20:00
Monopar Therapeutics Total Assets (Quarterly) : 137.98M for March 31, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Anika Therapeutics, Inc. | 179.39M |
| BioCryst Pharmaceuticals, Inc. | 465.05M |
| Plus Therapeutics, Inc. | 19.92M |
| Perspective Therapeutics, Inc. | 410.77M |
| AVITA Medical, Inc. | 51.54M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 2.589M |
| Shareholders Equity (Quarterly) | 135.39M |
| Debt to Equity Ratio | 0.001 |
| Current Ratio | 56.05 |
| Net Debt Paydown Yield | -0.01% |